Emergent BioSolutions Inc. Company Profile
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.07+0.12 (+1.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Emergent BioSolutions at a glance
Emergent BioSolutions Inc. (NYSE: EBS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2006. At a market capitalization of $356.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001367644, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Emergent BioSolutions Inc.
- Ticker
- NYSE: EBS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2006
- Market cap
- $356.35M
- SEC CIK
- 0001367644
Companies similar to Emergent BioSolutions
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ENTAEnanta Pharmaceuticals Inc. | 12.37 | +1.64% | $360.28M | vs EBS |
| ARCTArcturus Therapeutics Holdings Inc. | 12.77 | -1.81% | $362.82M | vs EBS |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs EBS |
| RLMDRelmada Therapeutics Inc. | 3.25 | -0.91% | $346.68M | vs EBS |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs EBS |
| TTRXTurn Therapeutics Inc. | 12.10 | +3.95% | $367.45M | vs EBS |
| CYPHCypherpunk Technologies Inc. | 3.05 | -6.44% | $328.68M | vs EBS |
| BNTCBenitec Biopharma Inc. | 8.99 | -0.11% | $313.60M | vs EBS |